These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. The Structure, Activity, and Function of the SETD3 Protein Histidine Methyltransferase. Witecka A; Kwiatkowski S; Ishikawa T; Drozak J Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685411 [TBL] [Abstract][Full Text] [Related]
15. Structural and Energetic Origin of Different Product Specificities and Activities for SETD3 and Its Mutants on the Methylation of the β-Actin H73K Peptide: Insights from a QM/MM Study. Zhao YY; Xu XL; Deng H; Wang KN; Rahman A; Ma Y; Shaik F; Wang CM; Qian P; Guo H J Chem Theory Comput; 2023 Jan; 19(1):349-362. PubMed ID: 36520638 [TBL] [Abstract][Full Text] [Related]
16. The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis. Chen Z; Yan CT; Dou Y; Viboolsittiseri SS; Wang JH Haematologica; 2013 May; 98(5):739-43. PubMed ID: 23065515 [TBL] [Abstract][Full Text] [Related]
17. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3. Jayaram H; Hoelper D; Jain SU; Cantone N; Lundgren SM; Poy F; Allis CD; Cummings R; Bellon S; Lewis PW Proc Natl Acad Sci U S A; 2016 May; 113(22):6182-7. PubMed ID: 27185940 [TBL] [Abstract][Full Text] [Related]
18. SETD3 is a mechanosensitive enzyme that methylates actin on His73 to regulate mitochondrial dynamics and function. Deshmukh V; Martin JF J Cell Sci; 2024 Jul; 137(14):. PubMed ID: 38896010 [TBL] [Abstract][Full Text] [Related]
19. Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis. Cheng X; Hao Y; Shu W; Zhao M; Zhao C; Wu Y; Peng X; Yao P; Xiao D; Qing G; Pan Z; Yin L; Hu D; Du HN J Biol Chem; 2017 Jun; 292(22):9022-9033. PubMed ID: 28442573 [TBL] [Abstract][Full Text] [Related]
20. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma. Xu L; Wang P; Feng X; Tang J; Li L; Zheng X; Zhang J; Hu Y; Lan T; Yuan K; Zhang Y; Ren S; Hao X; Zhang M; Xu M Clin Sci (Lond); 2019 Oct; 133(20):2085-2105. PubMed ID: 31654063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]